Tebu-bio, Toray Reach Agreement for miRNA, mRNA Profiling Technology | GenomeWeb

NEW YORK (GenomeWeb) – Tebu-bio today announced an agreement to offer Toray's 3D-Gene miRNA and mRNA profiling technology to European researchers.

Tokyo-based Toray has been offering the platform in Japan for years, and the deal announced today is part of its plans to expand into Europe by entering into strategic collaborations. France-based Tebu-bio is now certified by Toray to provide the 3D-Gene Platform Expression Profiling Technology as a service in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.